论文信息 - Obinutuzumab (GA101) plus CHOP or FC in relapsed/refractory follicular lymphoma: results of the GAUDI study (BO21000). - 字舞流文

Obinutuzumab (GA101) plus CHOP or FC in relapsed/refractory follicular lymphoma: results of the GAUDI study (BO21000).

G. Salles | J. Radford | R. Marcus | A. Davies | F. Morschhauser | G. Cartron | U. Vitolo | M. Wenger | G. Lei | Elisabeth Wassner-Fritsch